Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NeuroPrex Inc.

www.neuroprexinc.com

Latest From NeuroPrex Inc.

NeuroPrex: TMS For Treating Depression

NeuroPrex Inc. has developed a transcranial magnetic stimulation device for patients who are unable to take anti-depressants. Its NeuroPrex Classic & Shield is designed to deliver deep, localized energy noninvasively to trigger new synaptic connections and reverse stress-induced neural changes.

Medical Device

NeuroPrex Inc.

NeuroPrex Inc. has developed a transcranial magnetic stimulation device for patients who are unable to take anti-depressants. Its NeuroPrex Classic & Shield is designed to deliver deep, localized energy noninvasively to trigger new synaptic connections and reverse stress-induced neural changes.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NeuroPrex Inc.
  • Senior Management
  • Janice Huang, PhD, CEO
  • Contact Info
  • NeuroPrex Inc.
    Phone: (408) 688-1707
    2040 Martin Ave.
    Santa Clara, CA 95050
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register